Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPSTER
NCT07378215Phase 4Recruiting
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Jan 2026
- Primary completion
- Feb 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Ziekenhuis Oost-Limburg. Primary endpoint: Health-related quality of life at Day 90. Started Jan 2026; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07378215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07378215.